Skip to main content

BRISTOL JOHN W & CO INC /NY/

Position in NVS — Novartis AG

CIK 276101 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$87,414,810
+$1,594,209 QoQ
Shares Held
557,777
-0.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#40
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 1% None 2%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BRISTOL JOHN W & CO INC /NY/ holds $175,930,466 across 2 Drug Manufacturers - General names. NVS ranks #2 (49.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVS
Novartis AG
This page
557,777 $87,414,810

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $87,414,810 557,777
2026-03-31 $85,820,601 561,837
2025-12-31 $78,547,020 569,718
2025-09-30 $74,600,157 581,723
2025-06-30 $71,671,923 592,281
2025-03-31 $66,188,574 593,726
2024-12-31 $59,328,154 609,682
2024-09-30 $71,739,008 623,709
2024-06-30 $66,529,301 624,923
2024-03-31 $61,767,714 638,558
2023-12-31 $64,898,972 642,755
2023-09-30 $68,797,160 675,409
2023-06-30 $68,874,101 682,530
2023-03-31 $63,205,932 687,021
2022-12-31 $61,980,176 683,203
2022-09-30 $51,661,412 679,666
2022-06-30 $58,316,739 689,894
2022-03-31 $62,181,229 708,618
2021-12-31 $63,457,735 725,480
2021-09-30 $60,046,473 734,244
2021-06-30 $67,998,251 745,268
2021-03-31 $64,199,240 751,044
2020-12-31 $71,268,680 754,725
2020-09-30 $65,726,280 755,822
2020-06-30 $65,643,259 751,583
2020-03-31 $63,336,522 768,181